220 related articles for article (PubMed ID: 1823842)
1. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Schvartz C; Gibold C; Vuillemin B; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
[TBL] [Abstract][Full Text] [Related]
2. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
[TBL] [Abstract][Full Text] [Related]
3. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
[TBL] [Abstract][Full Text] [Related]
4. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
Fischer M
J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
[TBL] [Abstract][Full Text] [Related]
5. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
Hoefnagel CA; Schornagel J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
Colombo L; Lomuscio G; Vignati A; Dottorini ME
J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
[TBL] [Abstract][Full Text] [Related]
7. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
[TBL] [Abstract][Full Text] [Related]
10. Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.
Ackery DM; Troncone L
J Nucl Biol Med (1991); 1991; 35(4):318-20. PubMed ID: 1823846
[No Abstract] [Full Text] [Related]
11. 131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.
Sakahara H; Endo K; Saga T; Hosono M; Kobayashi H; Konishi J
Ann Nucl Med; 1994 May; 8(2):133-7. PubMed ID: 7521194
[TBL] [Abstract][Full Text] [Related]
12. [131I]metaiodobenzylguanidine therapy in paraganglioma.
Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
[TBL] [Abstract][Full Text] [Related]
14. The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases.
Troncone L; Rufini V; Maussier ML; Valenza V; Daidone MS; Luzi S; De Santis M
J Nucl Biol Med (1991); 1991; 35(4):327-31. PubMed ID: 1823849
[TBL] [Abstract][Full Text] [Related]
15. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
Lewington VJ; Zivanovic MA; Tristam M; McEwan AJ; Ackery DM
J Nucl Biol Med (1991); 1991; 35(4):280-3. PubMed ID: 1823836
[TBL] [Abstract][Full Text] [Related]
16. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
[TBL] [Abstract][Full Text] [Related]
17. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
Hoefnagel CA; Taal BG; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
[TBL] [Abstract][Full Text] [Related]
18. 131I-MIBG therapy of neural crest tumours (review).
Troncone L; Rufini V
Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
[TBL] [Abstract][Full Text] [Related]
19. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
Schvartz C; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
